Hormone Receptor Positive Tumor Active Not Recruiting Phase 2 Trials for Abemaciclib (DB12001)

IndicationStatusPhase
DBCOND0075370 (Hormone Receptor Positive Tumor)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02675231A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast CancerTreatment